Abstract
1. Pentobarbitone or phenobarbitone, in increasing concentrations up to 0-5 mM, progressively reduced the amplitude of miniature end-plate potentials (min.e.p.p.s). Pentobarbitone was the more potent of the two barbiturates in this regard. 2. Both barbiturates produced a monotonic increase in mean quantum content of the end-plate potential (e.p.p.) with increasing concentrations up to 0-5 mM. Pentobarbitone and phenobarbitone were equally potent in their action on evoked transmitter release. 3. The effect, if any, of increasing concentrations of barbiturates on the e.p.p. amplitude was depression. Therefore, over the range of concentrations examined the enhancement of transmitter release was quantitatively less than the reduction in responsiveness of the post-synaptic membrane. 4. Because of the greater ratio of post-synaptic to presynaptic actions, pentobarbitone was more potent than phenobarbitone in reducing synaptic efficacy (e.p.p. amplitude). 5. It is concluded that the presynaptic actions of pentobarbitone and phenobarbitone contribute significantly to barbiturate-induced changes in synaptic efficacy at low levels of transmitter release in the frog neuromuscular junction.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adams P. R., Cash H. C., Quilliam J. P. Extrinsic and intrinsic acetylcholine and barbiturate effects on frog skeletal muscle. Br J Pharmacol. 1970 Nov;40(3):552P–553P. [PMC free article] [PubMed] [Google Scholar]
- DEL CASTILLO J., KATZ B. Quantal components of the end-plate potential. J Physiol. 1954 Jun 28;124(3):560–573. doi: 10.1113/jphysiol.1954.sp005129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KATZ B., THESLEFF S. On the factors which determine the amplitude of the miniature end-plate potential. J Physiol. 1957 Jul 11;137(2):267–278. doi: 10.1113/jphysiol.1957.sp005811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuno M., Turkanis S. A., Weakly J. N. Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog. J Physiol. 1971 Mar;213(3):545–556. doi: 10.1113/jphysiol.1971.sp009399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MARTIN A. R. A further study of the statistical composition on the end-plate potential. J Physiol. 1955 Oct 28;130(1):114–122. doi: 10.1113/jphysiol.1955.sp005397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quastel D. M., Hackett J. T., Okamoto K. Presynaptic action of central depressant drugs: inhibition of depolarization-secretion coupling. Can J Physiol Pharmacol. 1972 Mar;50(3):279–284. doi: 10.1139/y72-042. [DOI] [PubMed] [Google Scholar]
- Seyama I., Narahashi T. Mechanism of blockade of neuromuscular transmission by pentobarbital. J Pharmacol Exp Ther. 1975 Jan;192(1):95–104. [PubMed] [Google Scholar]
- Thomson T. D., Turkanis S. A. Barbiturate-induced transmitter release at a frog neuromuscular junction. Br J Pharmacol. 1973 May;48(1):48–58. doi: 10.1111/j.1476-5381.1973.tb08221.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weakly J. N. Effect of barbiturates on 'quantal' synaptic transmission in spinal motoneurones. J Physiol. 1969 Sep;204(1):63–77. doi: 10.1113/jphysiol.1969.sp008898. [DOI] [PMC free article] [PubMed] [Google Scholar]